Endothelial and neural factors functionally involved in the modulation of noradrenergic vasoconstriction in healthy pig internal mammary artery

Biochem Pharmacol. 2012 Apr 1;83(7):882-92. doi: 10.1016/j.bcp.2011.12.038. Epub 2012 Jan 11.

Abstract

The role of endothelial and neural factors as modulators of neurogenic- and noradrenaline-induced vasoconstriction was examined in healthy pig internal mammary artery (IMA). Tetrodotoxin-, guanethidine-sensitive electrical field stimulation (EFS)-, and noradrenaline-elicited contractions were significantly diminished by prazosin (n=8, P<0.001) and less so by rauwolscine, indicating functional α₁- and α₂-adrenoceptor-mediated noradrenergic innervation of the IMA. Endothelium removal reduced neurogenic (n=8, P<0.01) but augmented noradrenaline responses (n=8, P<0.01), suggesting the release of two endothelium-dependent factors with opposite effects. In the presence of endothelium, neurogenic and exogenous noradrenaline vasoconstrictions were enhanced by L-NOArg (n=7, P<0.05 and P<0.01 respectively) and ODQ (n=7, both P<0.05); in denuded arteries, nNOS inhibition with N(ω)-propyl-L-arginine increased neurogenic contraction (n=7, P<0.05). Western blotting indicated the presence of neural and endothelial origin NO (n=6, P<0.001). Tetraethylammonium (n=9, P<0.001), iberiotoxin (n=7, P<0.001) and 4-aminopyridine (n=8, P<0.01) enhanced vasoconstrictions revealing a modulatory role of big conductance Ca²⁺-activated K⁺ (BK(Ca)) and voltage-dependent K⁺ (K(v)) channels in noradrenergic responses. Bosentan pretreatment (n=8, P<0.05) suggested endothelin-1 as the inferred contractile neurogenic endothelial-dependent factor. Indomethacin-induced inhibition involved a muscular prostanoid (n=9, P<0.05), functionally and immunologically localized, and derived from cyclooxygenase (COX)-1 and COX-2, as revealed by Western blots (n=5, P=0.1267). Thus, noradrenergic IMA contractions are controlled by contractile prostanoid activation and endothelin-1 release, and offset by BK(Ca) and K(v) channels and neural and endothelial NO. These results help clarify the mechanisms of vasospasm in IMA, as the preferred vessel for coronary bypass.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic Antagonists / pharmacology
  • Animals
  • Blotting, Western
  • Electric Stimulation
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / innervation
  • Endothelium, Vascular / metabolism
  • Endothelium, Vascular / physiology
  • Endothelium-Dependent Relaxing Factors / metabolism*
  • Immunohistochemistry
  • In Vitro Techniques
  • KATP Channels / metabolism
  • Male
  • Mammary Arteries / drug effects*
  • Mammary Arteries / innervation
  • Mammary Arteries / metabolism
  • Mammary Arteries / physiology
  • Muscarinic Antagonists / pharmacology
  • Nerve Fibers / drug effects
  • Nerve Fibers / metabolism
  • Nerve Fibers / physiology
  • Nitric Oxide / metabolism
  • Norepinephrine / pharmacology*
  • Norepinephrine / physiology
  • Potassium Channel Blockers / pharmacology
  • Potassium Channels, Calcium-Activated / metabolism
  • Potassium Channels, Voltage-Gated / metabolism
  • Prostaglandins / metabolism
  • Swine
  • Sympathetic Nervous System / drug effects*
  • Sympathetic Nervous System / physiology
  • Vasoconstriction / drug effects*
  • Vasoconstriction / physiology

Substances

  • Adrenergic Antagonists
  • Endothelium-Dependent Relaxing Factors
  • KATP Channels
  • Muscarinic Antagonists
  • Potassium Channel Blockers
  • Potassium Channels, Calcium-Activated
  • Potassium Channels, Voltage-Gated
  • Prostaglandins
  • Nitric Oxide
  • Norepinephrine